metaboCURE - Engineering synthetic gene circuits from bacterial metabolite-sensing operons for oncometabolic elimination of cancer
Projektnummer
0071445
Zusammenfassung
As many modern cancer therapies fail or lead to a relapse, new strategies to treat cancer are required. Numerous types of cancer accumulate the so-called oncometabolites, by-products of metabolism that promote cancer growth. One example is D-2-hydroxyglutarate (D-2-HG), which accumulates more than 100- to 1000-fold due to a mutation in a gene called IDH. Oncometabolites have not yet been used as a therapeutic target as there are no suitable biological sensors. However, a natural D-2-HG sensor was recently identified in bacteria that regulates the metabolism of D-2-HG as a nutrient sour...
Projektinformationen
Status:
Durchführung
Startdatum:
01.10.2024
Enddatum:
30.11.2027
Fördersumme:
573.600 €
Profilbereich:
Exploration
Förderinitiative:
Pioniervorhaben Exploration